Zoulim F, Zhang X, Pichoud C, Trepo C
Hepatitis and AIDS Research Unit, Lyon, France.
J Hepatol. 1996 Feb;24(2):155-60. doi: 10.1016/s0168-8278(96)80024-9.
We describe here the case of a patient suffering from severe chronic hepatitis B associated with an unusual hepatitis B virus serology: HBsAg and HBeAg were both positive while anti-HBc was negative by radioimmunoassay.
A very sensitive anti-HBc ELISA (IMx CORE) was performed and was able to detect anti-HBc sporadically throughout the clinical course. Molecular characterization of hepatitis B virus strains in this patient enabled us to explain this particular serological and clinical pattern of hepatitis B virus infection.
Hepatitis B virus genotype determined by size polymorphism of the core gene and the pre-S region was found to be D/E and consistent with the results of serological subtyping (HBV ayw2-4). DNA sequence analysis of the pre-C/C region showed the presence of significant nucleotide changes. In association with a wild type hepatitis B virus strain, we could detect at least four hepatitis B virus variants with nucleotide deletions leading to a frameshift in the core gene. According to the position of the mutations, these hepatitis B virus core variants are expected to be defective for B-cell epitopes and TH-cell epitopes.
These mutations explain the low level production of anti-HBc antibody. It is noteworthy that the absence of detectable anti-HBc in serum was associated with severe liver damage, suggesting that the deficient humoral response to HBcAg was not accompanied by a cellular immune tolerance to HBc/eAg, the supposed target for cytotoxic T-cell lysis.
我们在此描述一例患有严重慢性乙型肝炎且伴有不寻常乙肝病毒血清学表现的患者:通过放射免疫测定法,乙肝表面抗原(HBsAg)和乙肝e抗原(HBeAg)均呈阳性,而乙肝核心抗体(抗-HBc)呈阴性。
进行了一种非常灵敏的抗-HBc酶联免疫吸附测定(IMx CORE),并能够在整个临床病程中偶尔检测到抗-HBc。对该患者乙肝病毒株进行分子特征分析,使我们能够解释这种特殊的乙肝病毒感染血清学和临床模式。
通过核心基因和前S区域的大小多态性确定的乙肝病毒基因型为D/E,与血清学分型结果(HBV ayw2 - 4)一致。前C/C区域的DNA序列分析显示存在显著的核苷酸变化。与野生型乙肝病毒株相关,我们能够检测到至少四种乙肝病毒变异体,其核苷酸缺失导致核心基因移码。根据突变位置,预计这些乙肝病毒核心变异体在B细胞表位和TH细胞表位方面存在缺陷。
这些突变解释了抗-HBc抗体的低水平产生。值得注意的是,血清中未检测到抗-HBc与严重肝损伤相关,这表明对HBcAg的体液免疫反应不足并未伴随着对HBc/eAg(细胞毒性T细胞裂解的假定靶标)的细胞免疫耐受。